Hepatology
Conference Coverage
Treatment withdrawal without prior liver biopsy found safe in well-controlled autoimmune hepatitis
Liver biopsy prior to treatment withdrawal in patients with well-controlled autoimmune hepatitis may be unnecessary, contrary to current...
Conference Coverage
Medicaid restrictions loosening on access to HCV therapies
BOSTON – Some state Medicaid directors have started to drop or loosen restrictions on access to direct-acting antiviral treatments for the...
Conference Coverage
Lack of health literacy and normal routine implicated in hepatitis B virus treatment nonadherence
BOSTON – Attention to health literacy, overcoming language barriers, and educating patients about the importance of maintaining a treatment...
Conference Coverage
Study eyed zinc for slowing progression of chronic liver disease
BOSTON - Oral zinc supplementation was associated with maintenance of liver function and suppression of hepatocellular carcinoma in a...
Conference Coverage
VIDEO: Obeticholic acid resulted in reduction of a biomarker for liver fibrosis in PBC
BOSTON – Obeticholic acid resulted in a significant reduction of a biomarker for liver fibrosis in patients with primary biliary cholangitis,...
News from the FDA/CDC
FDA approves tenofovir alafenamide for patients with chronic hepatitis B and liver disease
FDA has approved tenofovir alafenamide (marketed as Vemlidy by Gilead Sciences) for the treatment of adults with chronic hepatitis B virus...
Conference Coverage
Cenicriviroc was well-tolerated but did not outperform placebo across all endpoints
Conference Coverage
Therapeutic alternative to liver transplantation could be on horizon in NASH
BOSTON - A novel therapeutic approach to nonalcoholic steatohepatitis could one day mean sufferers of this severe form of nonalcoholic fatty...
Article
Interferon-free HCV treatment can lead to herpesvirus reactivation, experts say
Interferon-free direct-acting antiviral regimens for chronic hepatitis C virus infection can cause reactivation of herpesvirus, according to the...